Your browser doesn't support javascript.
loading
Shared sorrow, shared costs: cost-effectiveness analysis of the Empowerment group therapy approach to treat affective disorders in refugee populations.
Strupf, Michael; Hoell, Andreas; Bajbouj, Malek; Böge, Kerem; Wiechers, Maren; Karnouk, Carine; Kamp-Becker, Inge; Banaschewski, Tobias; Meyer-Lindenberg, Andreas; Rapp, Michael; Hasan, Alkomiet; Falkai, Peter; Habel, Ute; Heinz, Andreas; Plener, Paul; Kaiser, Franziska; Weigold, Stefanie; Mehran, Nassim; Übleis, Aline; Padberg, Frank.
Afiliación
  • Strupf M; Department of Psychiatry and Psychotherapy, LMU University Hospital, Munich, Germany.
  • Hoell A; Department of Psychiatry and Psychotherapy, Central Institute for Mental Health, Medical Faculty Mannheim/ University of Heidelberg, Mannheim, Germany.
  • Bajbouj M; Department of Psychiatry and Psychotherapy, Charité - Universitätsmedizin, Campus Benjamin Franklin, Berlin, Germany.
  • Böge K; Department of Psychiatry and Psychotherapy, Charité - Universitätsmedizin, Campus Benjamin Franklin, Berlin, Germany.
  • Wiechers M; Department of Psychiatry and Psychotherapy, LMU University Hospital, Munich, Germany.
  • Karnouk C; Department of Psychiatry and Psychotherapy, Charité - Universitätsmedizin, Campus Benjamin Franklin, Berlin, Germany.
  • Kamp-Becker I; Department of Child and Adolescent Psychiatry, Philipps-University Marburg, Marburg, Germany.
  • Banaschewski T; Department of Child and Adolescent Psychiatry and Psychotherapy, Central Institute of Mental Health, Medical Faculty Mannheim, University of Heidelberg, Mannheim, Germany.
  • Meyer-Lindenberg A; Department of Psychiatry and Psychotherapy, Central Institute for Mental Health, Medical Faculty Mannheim/ University of Heidelberg, Mannheim, Germany.
  • Rapp M; Social and Preventive Medicine, University of Potsdam, Potsdam, Germany.
  • Hasan A; Department of Psychiatry, Psychotherapy and Psychosomatic, Medical Faculty, University of Augsburg, Augsburg, Germany.
  • Falkai P; Department of Psychiatry and Psychotherapy, LMU University Hospital, Munich, Germany.
  • Habel U; Department of Psychiatry and Psychotherapy, RWTH Aachen University, Aachen, Germany.
  • Heinz A; Department of Psychiatry and Psychotherapy, Charité - Universitätsmedizin, Campus Mitte, Berlin, Germany.
  • Plener P; Department of Child and Adolescent Psychiatry and Psychotherapy, University of Ulm, Ulm, Germany; and Department of Child and Adolescent Psychiatry, Medical University of Vienna, Vienna, Austria.
  • Kaiser F; Department of Psychiatry and Psychotherapy, RWTH Aachen University, Aachen, Germany.
  • Weigold S; Department of Psychiatry and Psychotherapy, Charité - Universitätsmedizin, Campus Mitte, Berlin, Germany.
  • Mehran N; Department of Psychiatry and Psychotherapy, Charité - Universitätsmedizin, Campus Mitte, Berlin, Germany.
  • Übleis A; Department of Psychiatry and Psychotherapy, LMU University Hospital, Munich, Germany.
  • Padberg F; Department of Psychiatry and Psychotherapy, LMU University Hospital, Munich, Germany.
BJPsych Open ; 9(4): e113, 2023 Jun 22.
Article en En | MEDLINE | ID: mdl-37345544
ABSTRACT

BACKGROUND:

Refugees and asylum seekers (RAS) in Germany need tailored and resource-oriented mental healthcare interventions.

AIMS:

To evaluate the cost-effectiveness of group psychotherapy for RAS with moderate depressive symptoms.

METHOD:

This is a post hoc cost-effectiveness analysis of Empowerment group psychotherapy that was embedded in a stratified stepped and collaborative care model (SCCM) from the multicentre randomised controlled MEHIRA trial. One hundred and forty-nine participants were randomly assigned to SCCM or treatment as usual (TAU) and underwent Empowerment (i.e. level 3 of the SCCM for adults) or TAU. Effects were measured with the nine-item Patient Health Questionnaire (PHQ-9) and quality adjusted life-years (QALY) post-intervention. Health service and intervention costs were measured. Incremental cost-effectiveness ratios (ICER) were estimated and net monetary benefit (NMB) regressions with 95% confidence intervals were performed. Cost-effectiveness was ascertained for different values of willingness to pay (WTP) using cost-effectiveness acceptability curves for probable scenarios. Trial registration number NCT03109028 on ClinicalTrials.gov.

RESULTS:

Health service use costs were significantly lower for Empowerment than TAU after 1 year. Intervention costs were on average €409.6. Empowerment led to a significant change in PHQ-9 scores but not QALY. Bootstrapped mean ICER indicated cost-effectiveness according to PHQ-9 and varied considerably for QALY in the base case. NMB for a unit reduction in PHQ-9 score at WTP of €0 was €354.3 (€978.5 to -€269.9). Results were confirmed for different scenarios and varying WTP thresholds.

CONCLUSIONS:

The Empowerment intervention was cost-effective in refugees with moderate depressive symptoms regarding the clinical outcome and led to a reduction in direct healthcare consumption. Concerning QALYs, there was a lack of confidence that Empowerment differed from TAU.
Palabras clave

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Clinical_trials / Health_economic_evaluation / Prognostic_studies Aspecto: Patient_preference Idioma: En Revista: BJPsych Open Año: 2023 Tipo del documento: Article País de afiliación: Alemania

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Clinical_trials / Health_economic_evaluation / Prognostic_studies Aspecto: Patient_preference Idioma: En Revista: BJPsych Open Año: 2023 Tipo del documento: Article País de afiliación: Alemania